Aclaris Therapeutics
Price & Volume
Stats
See moreOpen | $2.63 |
Previous Close | $2.57 |
Day Range | $2.47-$2.63 |
52W Range | $0.95-$5.17 |
Market Cap | $275M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $27M |
Revenue Growth (YoY) | -53.2% |
Gross Profit (12 Mos) | -$76.9M |
Diluted EPS | -$0.52 |
News
See moreYahoo Finance • last year
15 Small-Cap Stocks with High Potential
Yahoo Finance • last year
Aclaris Therapeutics Announces Top-line Results from 12-Week Phase 2b Trial of Oral Zunsemetinib (ATI-450) for Moderate to Severe Rheumatoid Arthritis and Provides Corporate Update
Yahoo Finance • last year
Aclaris Therapeutics Inc (ACRS) Reports Q3 2023 Financial Results
Yahoo Finance • last year
Aclaris Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
About
CEO | Dr. Neal S. Walker D.O., M.D. |
Address | 701 Lee Road, Wayne, PA, United States, 19087 |
Sector | Healthcare |
Industry | Diagnostics & Research |
Full-Time Employees | 86 |
